Bausch & Lomb (BLCO) Short term Debt (2022 - 2026)
Bausch & Lomb's (BLCO) quarterly Short term Debt came in at $43.0 million in Q2 2026, up 975.0% on a YoY basis from $4.0 million in Q2 2025, and up 10.26% quarter-over-quarter from $39.0 million in Q1 2026.
Analysis
Bausch & Lomb (BLCO) Short term Debt (2022 - 2026) Analysis & Trends
Bausch & Lomb (BLCO) has reported Short term Debt for 5 consecutive years, with $43.0 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Short term Debt rose 975.0% year-over-year to $43.0 million; the trailing twelve-month figure through Jun 2026 stood at $43.0 million (up 975.0% YoY), and the FY2025 full-year result was $39.0 million, down 2.5% from the prior year.
- Short term Debt grew to $43.0 million in Q2 2026 per BLCO's latest filing, from $39.0 million in the prior quarter.
- Across five years, Short term Debt topped out at $43.0 million in Q2 2026 and bottomed at $4.0 million in Q3 2022.
- Historically, Short term Debt has averaged $17.7 million across 5 years, with a median of $5.5 million in 2024.
- The sharpest annual moves came in 2025 and 2026: Short term Debt retreated 2.5% in 2025, then surged 975.0% in 2026.
- Over 5 years, Short term Debt stood at $25.0 million in 2022, then advanced by 20.0% to $30.0 million in 2023, then soared by 33.33% to $40.0 million in 2024, then slipped by 2.5% to $39.0 million in 2025, then climbed by 10.26% to $43.0 million in 2026.
- According to Business Quant data, Short term Debt over the past three periods registered $43.0 million, $39.0 million, and $39.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn |
| 10 | Bausch & Lomb | 6.28 Bn | 5.90 Bn | 867.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 43.00 Mn |
| Mar 31, 2026 | 39.00 Mn |
| Dec 31, 2025 | 39.00 Mn |
| Sep 30, 2025 | 28.00 Mn |
| Jun 30, 2025 | 4.00 Mn |
| Mar 31, 2025 | 6.00 Mn |
| Dec 31, 2024 | 40.00 Mn |
| Sep 30, 2024 | 4.00 Mn |
| Jun 30, 2024 | 4.00 Mn |
| Mar 31, 2024 | 5.00 Mn |
| Dec 31, 2023 | 30.00 Mn |
| Sep 30, 2023 | 4.00 Mn |
| Jun 30, 2023 | 4.00 Mn |
| Mar 31, 2023 | 4.00 Mn |
| Dec 31, 2022 | 25.00 Mn |
| Sep 30, 2022 | 4.00 Mn |